REVEOS^® AUTOMATED WHOLE BLOOD PROCESSING SYSTEM CLEARED BY FDA FOR U.S. COMMERCIAL USE

Terumo Blood and Cell Technologies (Terumo BCT) announced U.S. Food and Drug Administration (FDA) clearance of the Reveos Automated Whole Blood Processing System, the first whole blood automation device available in the U.S. that processes whole blood into platelets and other components in a single centrifugation cycle. Automated processing of whole blood on the Reveos system, the only device of its kind globally, will enhance the blood and platelet supply for patients in the U.S.

Platelets are used to treat patients with many conditions, including trauma and cancer. Today, 94% of platelets available for transfusion in the U.S. come from apheresis, a process that draws a donor's blood, isolates desired components from it, and returns the rest of the blood to the donor, using platforms such as Terumo BCT's Trima Accel^® Automated Blood Collection System.​

Apheresis donations are not projected to keep up with increases in platelet usage. FDA's clearance of the automated Reveos system gives blood centres the added capacity to collect platelets from existing whole blood donations efficiently.

In Reveos, Terumo BCT brings to the U.S. a platform with an established track record following deployment in 52 countries over the past decade. Reveos is the only automated device to process whole blood into platelets, plasma and red blood cell (RBC) components in a single centrifugation cycle.

"Reveos will help blood centres maximize the use of whole blood donations while increasing the availability of platelets for patients in need," said Bill Block, President and CEO of Blood Centers of America, the largest blood supply network in the U.S. "We look forward to deploying this technology within our membership and at our blood centre partners across the country later this year."

By automating whole blood processing, Reveos can reduce the working hours needed by laboratory staff by up to 30%. Whole blood is collected from donors and has traditionally been separated into components using manual methods that take as many as 18 or 20 steps. Reveos simplifies this process and eliminates over half the steps.